Congratulations to Dr. Hans Wildiers, winner of the B.J. Kennedy Geriatric Oncology Award
7 Jun 2023
Congratulations to our longstanding member Dr. Hans Wildiers for receiving the B.J. Kennedy Geriatric Oncology Award at the 2023 ASCO Annual Meeting.
Created in 2007 in honour of B.J. Kennedy, MD, this award recognises an ASCO member who has made outstanding contributions to the research, diagnosis, and treatment of cancer in the elderly, and in bringing an understanding of geriatric oncology to fellows and junior faculty.
During the Award Lecture (session available on-demand for participants), Dr. Wildiers presented a session titled “Looking Back and Moving Forward” where he focused on the achievements in the field of geriatric oncology and the work that is still needed to improve the care of older patients with cancer.
During his presentation, he thanked organisations like EORTC, which have strongly supported geriatric oncology research in the last years.
“It is my great honour to receive this year’s the B.J. Kennedy Geriatric Oncology Award. […] Within the EORTC, we had a lot of discussions on the optimal trial design for older patients with cancer.”
– Dr. Hans Wildiers
Dr. Wildiers is a medical oncologist dedicated to breast cancer research. He has served as a staff member in the Department of Medical Oncology at the University Hospital Leuven, Belgium, since 2004. Since 2015, he has been the coordinator of the Leuven Multidisciplinary Breast Center. He has also been the coordinator of several academic studies in the field of breast cancer and geriatric oncology and is the author of more than 350 peer-reviewed papers. He has been active on the Board of the International Society of Geriatric Oncology for many years and served as the organisation’s president from 2018 to 2020. From 2009 to 2015, he chaired the Cancer in the Elderly Task Force of the European Organisation for Research and Treatment of Cancer (EORTC).
Related News
Meet the new EORTC Board
9 Jul 2024
We are pleased to announce the release of the EORTC 2023 Annual Report
17 Jun 2024
Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group
24 May 2024
Clinical Trials Day 2024: a Q&A on pragmatic clinical trials
20 May 2024
EORTC/EMA workshop suggests an international way forward for treatment optimisation studies
8 May 2024
EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024